Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique

Tissue Antigens. 2013 Dec;82(6):420-2. doi: 10.1111/tan.12226. Epub 2013 Oct 21.

Authors

H D Clifford¹, C M Hayden, S-K Khoo, D Naniche, I M Mandomando, G Zhang, P Richmond, P N Le Souëf

Affiliation

¹ School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia; Telethon Institute for Child Health Research and the Centre for Child Health Research, Perth, Western Australia, Australia.

PMID: 24147858
DOI: 10.1111/tan.12226

No abstract available

Keywords: Africa; CD14; measles; polymorphism; vaccine; vaccine failure.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Australia
Child
Child, Preschool
Cohort Studies
Female
Genetic Association Studies
Genotype
Humans
Immunity, Innate / genetics
Infant
Lipopolysaccharide Receptors / genetics*
Male
Measles / genetics
Measles / immunology*
Measles / prevention & control
Measles Vaccine / immunology*
Mozambique
Polymorphism, Single Nucleotide
Promoter Regions, Genetic / genetics*
Treatment Outcome
Vaccination

Substances

Lipopolysaccharide Receptors
Measles Vaccine